All Stories

  1. Scalable production of tissue-like vascularized liver organoids from human PSCs
  2. Deoxyribonucleoside treatment rescues EtBr‐induced mtDNA depletion in iPSC‐derived neural stem cells with POLG mutations
  3. Sensitivity of endogenous autofluorescence in HeLa cells to the application of external magnetic fields
  4. POLG genotype influences degree of mitochondrial dysfunction in iPSC derived neural progenitors, but not the parent iPSC or derived glia
  5. Aagenaes syndrome/lymphedema cholestasis syndrome 1 is caused by a founder variant in the 5’-untranslated region of UNC45A
  6. “iPSC-derived liver organoids and inherited bleeding disorders: Potential and future perspectives”
  7. “Organ-in-a-Column” Coupled On-line with Liquid Chromatography-Mass Spectrometry
  8. Comparing the mitochondrial signatures in ESCs and iPSCs and their neural derivations
  9. Models and Techniques to Study Aortic Valve Calcification in Vitro, ex Vivo and in Vivo. An Overview
  10. POLG mutations lead to abnormal mitochondrial remodeling during neural differentiation of human pluripotent stem cells via SIRT3/AMPK pathway inhibition
  11. Autophagy modulates cell fate decisions during lineage commitment
  12. Distinct Mitochondrial Remodeling During Mesoderm Differentiation in a Human-Based Stem Cell Model
  13. 3D Printed Tooling for Injection Molded Microfluidics
  14. Nicotinamide Riboside and Metformin Ameliorate Mitophagy Defect in Induced Pluripotent Stem Cell-Derived Astrocytes With POLG Mutations
  15. Distinct mitochondrial remodeling during early cardiomyocyte development in a human-based stem cell model
  16. ADVANCED PRECLINICAL MODELS FOR EVALUATION OF DRUG INDUCED LIVER INJURY - CONSENSUS STATEMENT BY THE EUROPEAN DRUG-INDUCED LIVER INJURY NETWORK [PRO-EURO-DILI-NET]
  17. Liver Organoids: Recent Developments, Limitations and Potential
  18. Increased p53 signaling impairs neural differentiation in HUWE1-promoted intellectual disabilities
  19. N-acetylcysteine amide ameliorates mitochondrial dysfunction and reduces oxidative stress in hiPSC-derived dopaminergic neurons with POLG mutation
  20. Electromembrane Extraction and Mass Spectrometry for Liver Organoid Drug Metabolism Studies
  21. How well do brain organoids capture your brain?
  22. Stem cell derived astrocytes with POLG mutations and mitochondrial dysfunction including abnormal NAD+ metabolism is toxic for neurons
  23. Scalable production of tissue-like vascularised liver organoids from human PSCs
  24. Characterizing Coagulation FVII from iPSC-Hepatocytes-like Cells: Setting the Basis for Cell Therapy Development
  25. A method for differentiating human induced pluripotent stem cells toward functional cardiomyocytes in 96-well microplates
  26. “Organoid-in-a-column” coupled on-line with liquid chromatography-mass spectrometry
  27. Disease‐specific phenotypes in iPSC ‐derived neural stem cells with POLG mutations
  28. Scalable small molecule derived mini-liver organoids from human pluripotent stem cells
  29. Dysregulation of BRD4 Function Underlies the Functional Abnormalities of MeCP2 Mutant Neurons
  30. Electromembrane extraction and mass spectrometry for liver organoid drug metabolism studies
  31. Synthetic Analyses of Single-Cell Transcriptomes from Multiple Brain Organoids and Fetal Brain
  32. 3D cell culture models and organ‐on‐a‐chip: Meet separation science and mass spectrometry
  33. Interstitial cells in calcified aortic valves have reduced differentiation potential and stem cell-like properties
  34. Inflammation and Mechanical Stress Stimulate Osteogenic Differentiation of Human Aortic Valve Interstitial Cells
  35. Uhrf1 regulates active transcriptional marks at bivalent domains in pluripotent stem cells through Setd1a
  36. Directed reprogramming of comprehensively characterized dental pulp stem cells extracted from natal tooth
  37. Rapid Screening of the Endodermal Differentiation Potential of Human Pluripotent Stem Cells
  38. Preclinical imaging methods for assessing the safety and efficacy of regenerative medicine therapies
  39. Valve Interstitial Cells: The Key to Understanding the Pathophysiology of Heart Valve Calcification
  40. Future Challenges in the Generation of Hepatocyte-Like Cells From Human Pluripotent Stem Cells
  41. Development of an inducible platform for intercellular protein delivery
  42. Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liver
  43. Development of a rapid screen for the endodermal differentiation potential of human pluripotent stem cell lines
  44. Small-Molecule-Directed Hepatocyte-Like Cell Differentiation of Human Pluripotent Stem Cells
  45. Chondrocytes Derived From Mesenchymal Stromal Cells and Induced Pluripotent Cells of Patients With Familial Osteochondritis Dissecans Exhibit an Endoplasmic Reticulum Stress Response and Defective Matrix Assembly
  46. Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells
  47. Investigation of Rett syndrome using pluripotent stem cells
  48. Comment on "Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells"
  49. Modelling Human Disease with Pluripotent Stem Cells
  50. FUS-SMN Protein Interactions Link the Motor Neuron Diseases ALS and SMA
  51. Cellular reprogramming: a novel tool for investigating autism spectrum disorders
  52. Role of Pluripotent Stem Cells in Regenerative Medicine
  53. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability
  54. Humanized murine model for HBV and HCV using human induced pluripotent stem cells
  55. Lineage-specific distribution of high levels of genomic
  56. The evolving biology of cell reprogramming
  57. Biomedical and social contributions to sustainability
  58. Induced pluripotent stem cells: epigenetic memories and practical implications
  59. Hepatic Endoderm Differentiation from Human Embryonic Stem Cells
  60. What are the limits to cell plasticity?
  61. Generation of functional human hepatic endoderm from human induced pluripotent stem cells
  62. A decade of progress since the birth of Dolly
  63. UBF Binding In Vivo Is Not Restricted to Regulatory Sequences within the Vertebrate Ribosomal DNA Repeat
  64. Human acrocentric chromosomes with transcriptionally silent nucleolar organizer regions associate with nucleoli
  65. Dimerization and HMG box domains 1-3 present in Xenopus UBF are sufficient for its role in transcriptional enhancement
  66. The Xenopus RNA polymerase I transcription factor, UBF, has a role in transcriptional enhancement distinct from that at the promoter
  67. Nucleotide sequence of a repetitive element isolated from Leptospira interrogans serovar hardjo type hardjo-bovis
  68. Development of a PCR test specific for Leptospira hardjo genotype bovis